Delivery Order SPE2DB22D1103-SPE2DB25FTPM8
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,123.23 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat respiratory conditions. The contract has an ultimate completion date of June 16, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,952,996 units of a pharmaceutical product, Budesonide-Formoterol 160-4.5 10.2 GM. The contract has a firm fixed price of $1,196.04 and a completion date of September 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its broader indefinite delivery contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a performance period extending through May 21, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a $2,075.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of budesonide-formoterol 80-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $5,673.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medical product, with a completion date of April 15, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $1,739.64 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,320.33, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,814.64, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,884.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 22, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,455.63, is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...